Journal
BONE MARROW TRANSPLANTATION
Volume 47, Issue 6, Pages 770-790Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/bmt.2011.185
Keywords
haematopoietic SCT; autoimmune diseases; autologous; allogeneic; guidelines; recommendations
Categories
Funding
- Bayer Schering
- Biogen Idec
- Sanofi-Aventis
- Merck Serono
- Novartis Pharmaceuticals
- TEVA/Sanofi-Aventis
- Biogen
- Novartis
Ask authors/readers for more resources
In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune diseases (ADs) were published, while an international coordinated clinical programme was launched. These guidelines provided broad principles for the field over the following decade and were accompanied by comprehensive data collection in the European Group for Blood and Marrow Transplantation (EBMT) AD Registry. Subsequently, retrospective analyses and prospective phase I/II studies generated evidence to support the feasibility, safety and efficacy of HSCT in several types of severe, treatment-resistant ADs, which became the basis for larger-scale phase II and III studies. In parallel, there has also been an era of immense progress in biological therapy in ADs. The aim of this document is to provide revised and updated guidelines for both the current application and future development of HSCT in ADs in relation to the benefits, risks and health economic considerations of other modern treatments. Patient safety considerations are central to guidance on patient selection and HSCT procedural aspects within appropriately experienced and Joint Accreditation Committee of International Society for Cellular Therapy and EBMT accredited centres. A need for prospective interventional and non-interventional studies, where feasible, along with systematic data reporting, in accordance with EBMT policies and procedures, is emphasized. Bone Marrow Transplantation (2012) 47, 770-790; doi:10.1038/bmt.2011.185; published online 17 October 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available